Summary
This 8-K filing from AmerisourceBergen Corporation (now Cencora, Inc.) on July 30, 2007, primarily concerns the finalization of the exchange ratios for the spin-off and combination of its institutional pharmacy services business with that of Kindred Healthcare, Inc. This transaction will result in the creation of PharMerica Corporation. The filing corrects previously announced ratios and confirms the closing date for the transaction as July 31, 2007. For investors, this filing is significant as it marks a key step in the divestiture of AmerisourceBergen's institutional pharmacy operations. The finalization of exchange ratios is crucial for shareholders to understand their potential stake in the newly formed entity, PharMerica. The prompt completion of this strategic move indicates efficient execution of the company's plan to streamline its business focus.
Key Highlights
- 1AmerisourceBergen announced the final exchange ratios for the distribution of PharMerica Corporation shares.
- 2The transaction involves the spin-off and combination of AmerisourceBergen's and Kindred Healthcare's institutional pharmacy services businesses.
- 3The newly formed entity will be named PharMerica Corporation.
- 4The filing corrects previously announced exchange ratios from July 26, 2007.
- 5The closing date for this transaction is scheduled for July 31, 2007.
- 6This event signifies AmerisourceBergen's strategic decision to divest its institutional pharmacy services segment.